HVRR.Y, the OTC-listed American depositary receipt for Hannover Rück SE, heads into its May 11 earnings date with borrow availability fully exhausted and short interest up sharply over the past week.
The lending market tells the most striking story this week. Availability has fallen to zero — every share in the lending pool is currently lent out, the tightest the borrow market has been in the available data. That mirrors utilization at 100%, a level also at its 52-week peak. The shift has been fast. As recently as April 20, only around 39% of available shares had been borrowed. By April 28, the pool was fully depleted. Short interest itself jumped 63% week-on-week to approximately 25,660 shares on the ORTEX daily estimate, though the most recent official FINRA fortnightly figure puts borrowed shares at 30,293. Cost to borrow has been easing gradually — now running at 6.8%, down from above 9% in late March — suggesting the squeeze on availability has not yet translated into a premium on new borrows. That could change if fresh demand hits a pool with nothing left to lend.
The short score, an ORTEX composite signal, climbed to 50.1 on April 28, its highest reading in the 10-day window and up from 44.5 just 12 days earlier. By itself the level is moderate, but the direction of travel matters: the score has risen in five of the last six sessions, tracking the availability squeeze almost exactly. The dtc rank sits at the 10th percentile and the utilization rank at the 18th percentile — neither extreme, but both consistent with a stock where short positioning is building rather than unwinding.
The price action reinforces the cautious tone. The ADR closed at $49.66 on April 29, down 3.9% on the day and off 8% on the week, even as the one-month change remains nearly flat at +0.5%. That divergence — steady over a month but sharply lower over five days — suggests recent selling pressure is idiosyncratic rather than trend-driven. A separate news item noted that Munich Re's €5.3bn payout package failed to lift European reinsurers this week, with the sector caught in a broader selloff. Hannover Re's primary Frankfurt listing (HNR1) has been dragged along with peers. Earlier this week, Hannover Re also announced a collaboration with Schroders Capital, though the market's reaction was muted in the context of sector-wide weakness.
On fundamentals, the available data is limited for the OTC listing but the Frankfurt primary figures indicate a business generating estimated revenue of around €32.5bn and net income of approximately €3.3bn. The EV/EBIT multiple on current estimates is 8.3x. The dividend score ranks at the 97th percentile — Hannover Re's dividend track record is a core part of the investment case, though the dividend history in this data feed is stale (last recorded event dates to May 2022). The EPS surprise percentile of 62 suggests a modest but consistent tendency to beat consensus estimates. EPS momentum, however, is softer — both the 30-day and 90-day readings rank below the median, at the 35th and 37th percentiles respectively.
Ownership is anchored. HDI Haftpflichtverband holds 50.2% of shares, a controlling stake that has barely moved. Beyond that, BlackRock added roughly 58,000 shares through March 31 and Vanguard added 34,000. Norges Bank Investment Management built a more meaningful position over the reporting period, adding 266,000 shares. Institutional interest is incremental rather than dramatic, with no large-scale buying or selling evident at the top of the register.
With the May 11 earnings release approaching, the immediate question is whether the rapid tightening of availability — zero headroom in the borrow market as of April 28 — persists, eases, or pushes cost-to-borrow back toward the March highs above 9%.
See the live data behind this article on ORTEX.
Open HVRR.Y on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
